"A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCeptTM, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability"
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Women's Community & Population Health
Awarded By
Sebela Pharmaceuticals, Inc.
Start Date
January 2, 2019
End Date
October 31, 2023
Administered By
Obstetrics and Gynecology, Women's Community & Population Health
Awarded By
Sebela Pharmaceuticals, Inc.
Start Date
January 2, 2019
End Date
October 31, 2023